The victim of a February robbery outside Thunderbird Lanes provides key details to authorities during separate investigation, ...

Growth of the local leadership team may foreshadow a renewed push for conservative cultural causes in Bucks County districts.

In what’s become a feature of the polarized political climate, the online outrage cycle ended with social media vigilantes ...

Arbutus Biopharma Corporation (Nasdaq: ABUS) has announced its financial results for the fourth quarter and fiscal year 2024, ...

Arbutus Biopharma restructures to cut costs & focus on Hepatitis B drug imdusiran. Read more about ABUS stock here.

Gary Martin makes The Bowerman Watchlist third update announced by The Bowerman Men’s Watch List Committee in conjunction ...

This weekend, it will be supporters of Trump and Musk who will be hitting the pavement at 700 York Road. A flyer is making ...

Arbutus Biopharma (NASDAQ:ABUS) stock gains as the company announces a restructuring drive with a 57% workforce reduction.

The Board also decided to exit the Company's corporate headquarters in Warminster, PA, and to discontinue in-house scientific research. In connection with these actions, the Company expects to incur a ...

In March 2025, the Company’s Board took action to reduce the Company’s workforce by 57% resulting in a total workforce after reductions of 19 ...